PPIG and chronic cystitis: The intravesical administration of botulinum toxin A suppressed bladder hyperactivity and inflammation in CYP-stimulated cystitis by downregulating the expressions of COX-2 and EP4, which are both upregulated in bladder and spinal cord after CYP treatment [5].